Profiting from warnings, asset managers and Johnson & Johnson: Companies and Markets Show

Third-quarter earnings season (Q3) is under way and it’s taking place amid some renewed wobbles for AI and chip stocks.

With this in mind, this week’s show considers two companies that could be construed as defensive. First, we turn to emerging market-focused asset manager Ashmore – while not the most obvious port in a storm, its focus on debt rather than stocks means it offers resilience. Mark Robinson explains its recent trading update.

We then look at healthcare giant Johnson & Johnson, perhaps less of a defensive staple than it once was following the spin-off of its consumer division, but still a potential haven nonetheless. Julian Hofmann has the details and explores why, after a good year so far, its Q3 figures were not well received.

Julian also dives into this week’s Big Read: How to profit from profit warnings. He talks through recent trends, market reactions and what it all means for the wider economy.

Timestamps:
00:00 Intro
01:02 Ashmore
10:16 Profiting from profit warnings
23:14 Johnson & Johnson

Listen to more podcasts from Investors’ Chronicle on Apple (podcasts.apple.com/gb/podcast/investors-chroni…), Spotify (open.spotify.com/show/0UXC2zQdVzl1n57gqO5oBp) and YouTube (youtube.com/user/InvestorsChronicle)

Investors' Chronicle (investorschronicle.co.uk/?utm_medium=referral&…) has supported private investors in the UK for over 160 years by highlighting rewarding investorschronicle.co.uk/investment-ideas/?utm… opportunities.

Investors' Chronicle is a service by the Financial Times (ft.com/?utm_medium=referral&utm_source=aca…).
Hosted on Acast. See acast.com/privacy for more information.